Dr Wee Hwee Lin

Joint Assistant Professor, Saw Swee Hock School of Public Health and Department of Pharmacy, Faculty of Science, National University of Singapore

Dr Wee is a joint Assistant Professor in the Saw Swee Hock School of Public Health and Department of Pharmacy, Faculty of Science at the National University of Singapore. Her current work involves understanding patient preferences for high cost treatments, public preferences for preemptive pharmacogenetic testing and factors associated with well-being among Singaporeans.

Dr Yot Teerawattananon

Founding Leader, Health Intervention and Technology Assessment Program, Thailand
Visiting Professor, Saw Swee Hock School of Public Health, National University of Singapore

Dr Yot Teerawattananon is a Founding Leader of the HITAP of the Thai Ministry of Public Health of which its works have been used to inform health benefit package of the Universal Health Coverage Scheme. He previously served as a medical doctor and director of Pong Hospital in northern Thailand before completing his Ph.D. in Health Economics from UK in 2006. Dr Yot has gone on to provide technical advice to many national and international agencies such as the Gates Foundation, WHO, World Bank, Asian Development Bank and the Centre for Global Development (CGD), giving him a broad knowledge of key is-sues in global health. He has also worked in Bhutan, India, Indonesia, Kenya, Myanmar, Nepal, Sri Lanka, the Philippines, and Vietnam. He is also in the World Health Report 2013 of the World Health Organization as a role model organization informing policy decisions to support Universal Health Coverage in resource limited settings. Dr Yot is also one of the founders of HTAsiaLink a regional network comprising of governmental health technology assessment agencies throughout Asia.

Dr Wang Yi

Senior Research Fellow, Saw Swee Hock School of Public Health, National University of Singapore

Dr. Wang Yi is currently a senior research fellow at Health Intervention and Policy Evaluation Research (HIPER) at SSHSPH leading the Health Technology Assessment (HTA) Team. His research areas include health technology assessment, early health technology assessment, contingent valuation and health economics. His recent focus is on early health technology assessment to promote efficient medical innovation processes and developing research frameworks to evaluate precision medicine.

Ms Fiona Pearce 

Senior Advisor, Agency for Care Effectiveness, Ministry of Health, Singapore

Ms Fiona Pearce is a Senior Advisor to the Agency for Care Effectiveness (ACE), Singapore’s national HTA agency, providing technical support to the Health Technology Assessment (HTA) and Consumer Engagement and Education (CEE) work streams. She is one of the founding members of ACE and was responsible for developing the HTA methods and processes which the agency uses to conduct evaluations of drugs and vaccines to inform national subsidy decisions. She was also involved in establishing Singapore’s national Rare Disease Fund in 2019 which provides long-term, financial support to patients with rare genetic diseases who require high-cost treatments.

Professor Stephen Jan

Co-Director, Health Systems Research, The George Institute for Global Health

Prof Stephen Jan is Head of the Health Economics and Process Evaluation Program and Co-Director, Health System Science at the George Institute for Global Health and Conjoint Professor at the University of New South Wales.

He is an Honorary Professor at the University of Sydney, a Director of the Sax Institute and an Associate at both the Menzies Centre for Health Policy and the Poche Centre for Indigenous Health. He is a current NHMRC Principal Research Fellow and has previously held posts at the London School of Hygiene and Tropical Medicine and the Centre for Health Economics Research and Evaluation (CHERE) in Sydney. Stephen has over 20 years of experience in health economics, has published over 200 scientific articles and authored two textbooks in health economics.

He has worked closely with various governments of different levels, both in Australia (Commonwealth and State) and overseas, with international agencies such as the WHO and industry. His areas of expertise are economic evaluation, health financing, health sector priority setting, Indigenous and global health issues and the economics of chronic disease.